Pediatrix Medical Group, Inc. financial data

Symbol
MD on NYSE
Location
Sunrise, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 19 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 177% % 19%
Debt-to-equity 153% % -12%
Return On Equity 20% %
Return On Assets 7.7% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,001,072 shares -3.3%
Common Stock, Shares, Outstanding 82,976,110 shares -3.4%
Entity Public Float $899,915,751 USD 41%
Common Stock, Value, Issued $830,000 USD -3.4%
Weighted Average Number of Shares Outstanding, Basic 84,080,000 shares 0.9%
Weighted Average Number of Shares Outstanding, Diluted 85,268,000 shares 2.3%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $240,791,000 USD 0.99%
Operating Income (Loss) $208,813,000 USD 24%
Nonoperating Income (Expense) $7,619,000 USD 46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $216,432,000 USD 37%
Income Tax Expense (Benefit) $51,044,000 USD 318%
Net Income (Loss) Attributable to Parent $165,388,000 USD 11%
Earnings Per Share, Basic 1.97 USD/shares 11%
Earnings Per Share, Diluted 1.94 USD/shares 8.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $375,241,000 USD 63%
Accounts Receivable, after Allowance for Credit Loss, Current $229,665,000 USD -12%
Other Assets, Current $8,879,000 USD 75%
Assets, Current $763,514,000 USD 19%
Deferred Income Tax Assets, Net $73,922,000 USD -29%
Property, Plant and Equipment, Net $39,180,000 USD 0.02%
Operating Lease, Right-of-Use Asset $31,132,000 USD -8.7%
Goodwill $1,260,732,000 USD 1.5%
Other Assets, Noncurrent $58,156,000 USD -24%
Assets $2,246,696,000 USD 4.4%
Accounts Payable, Current $37,220,000 USD -20%
Liabilities, Current $458,911,000 USD 5.7%
Long-term Debt and Lease Obligation $570,532,000 USD -4.5%
Deferred Income Tax Liabilities, Net $57,024,000 USD 67%
Operating Lease, Liability, Noncurrent $25,686,000 USD -20%
Other Liabilities, Noncurrent $30,336,000 USD -7.8%
Liabilities $1,380,842,000 USD -0.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $610,000 USD
Retained Earnings (Accumulated Deficit) $83,152,000 USD 67%
Stockholders' Equity Attributable to Parent $865,854,000 USD 13%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $865,854,000 USD 13%
Liabilities and Equity $2,246,696,000 USD 4.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $117,463,000 USD 6.2%
Net Cash Provided by (Used in) Financing Activities $6,035,000 USD -108%
Net Cash Provided by (Used in) Investing Activities $7,464,000 USD 54%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 82,976,110 shares -3.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $130,962,000 USD -101%
Deferred Tax Assets, Valuation Allowance $29,654,000 USD -93%
Deferred Tax Assets, Gross $216,941,000 USD -68%
Operating Lease, Liability $37,277,000 USD -17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $167,069,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $41,031,000 USD -18%
Property, Plant and Equipment, Gross $171,515,000 USD 3.5%
Operating Lease, Liability, Current $11,591,000 USD -8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,199,000 USD -8.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,433,000 USD -9.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.059 pure 0%
Deferred Income Tax Expense (Benefit) $4,398,000 USD 541%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,754,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,849,000 USD -19%
Deferred Tax Assets, Operating Loss Carryforwards $118,405,000 USD 147%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $1,023,000 USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,710,000 USD -26%
Depreciation, Depletion and Amortization $21,827,000 USD -32%
Deferred Tax Assets, Net of Valuation Allowance $187,287,000 USD -23%
Share-based Payment Arrangement, Expense $11,700,000 USD 18%
Interest Expense $41,362,000 USD 0.67%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%